Octavius Pharma has developed DC granules of Alendronate Sodium for making Alendronate Sodium tablets. Product has been developed to produce uniform particles that help give excellent flow-ability in a way that facilitates tablet compression to maintain content uniformity and Consistent stability throughout shelf life. Finished Product complies as per USP specifications.
| Strength | 70 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | USP |
| API DMF | Available |
| CTD Dosssier | Available |
Alendronate Sodium: Alendronate is US FDA approved for the treatment of postmenopausal osteoporosis, steroid-induced osteoporosis, and male osteoporosis, as well as for the management of Paget disease of bone. It belongs to the class of bisphosphonate medications, which aids in the prevention of bone resorption and the promotion of bone density.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields